# SAMSN1

## Overview
SAMSN1 is a gene that encodes the protein SAM domain, SH3 domain, and nuclear localization signals 1, which functions primarily as an adaptor or scaffold protein. This protein is characterized by the presence of a SAM (sterile alpha motif) domain and an SH3 (Src homology 3) domain, which facilitate its role in cellular signaling pathways by mediating protein-protein interactions. SAMSN1 is involved in various cellular processes, including signal transduction and immune response regulation, particularly influencing B-cell activation and differentiation. The protein's nuclear localization signals suggest additional roles within the nucleus, potentially affecting gene expression. SAMSN1 has been implicated in angiogenesis and vascular development, indicating its involvement in broader developmental processes. Its interactions with proteins such as KEAP1 and cortactin highlight its significance in immune regulation and cancer pathogenesis (Li2024SAMSN1; Gitton2002A; Yan2013SAMSN1).

## Function
SAMSN1 is a gene that encodes a protein involved in several cellular processes, particularly in signal transduction and immune response regulation. The protein contains a SAM (sterile alpha motif) domain and an SH3 (Src homology 3) domain, which are indicative of its role as an adaptor or scaffold protein, facilitating interactions with other proteins. These domains are crucial for the protein's involvement in cellular signaling pathways, where it may act to link signaling molecules and modulate downstream effects (Gitton2002A).

In healthy human cells, SAMSN1 is implicated in the regulation of B-cell activation and differentiation, which are essential processes in the immune system. The protein's ability to influence these processes suggests a role in maintaining immune homeostasis and proper immune responses. The presence of nuclear localization signals within the SAMSN1 protein indicates that it may also have functions within the nucleus, potentially influencing gene expression or other nuclear processes (Gitton2002A).

The expression of SAMSN1 has been associated with blood vessel formation, although the precise mechanisms and functions in this context are not fully detailed. This suggests a potential role in angiogenesis or vascular development, contributing to its involvement in broader developmental processes (Gitton2002A).

## Clinical Significance
The SAMSN1 gene has been implicated in several diseases due to mutations, altered expression levels, or changes in its interactions. In systemic lupus erythematosus (SLE), SAMSN1 is involved in the post-BCR BLK signaling pathway. Mutations such as the SAMSN1 T198A variant can lead to altered immune responses, contributing to SLE pathogenesis. This variant, when introduced into mouse models, resulted in symptoms mimicking human SLE, including the presence of anti-nuclear antibodies and kidney involvement (jiang2015contribution).

In glioblastoma multiforme (GBM), SAMSN1 is highly expressed and associated with poor survival outcomes. High SAMSN1 expression correlates with shorter progression-free survival and overall survival, making it a significant prognostic marker in GBM. The gene's expression is notably higher in gliomas compared to normal brain tissue, and its elevated levels are linked to increased tumor size and non-clear boundaries, suggesting enhanced tumor aggressiveness (Yan2013SAMSN1).

In lung cancer, SAMSN1 is frequently downregulated, although no somatic mutations were detected. Its reduced expression suggests a potential role as a tumor suppressor gene, although its direct involvement in lung cancer pathogenesis remains unclear (Yamada2008Detailed).

## Interactions
SAMSN1 is involved in several protein interactions that play a significant role in cellular processes. It interacts with Kelch-like ECH-associated protein 1 (KEAP1), which is crucial for the regulation of the KEAP1-NRF2 signaling pathway. SAMSN1 binds to KEAP1, leading to the dissociation of the KEAP1-NRF2 complex. This interaction allows NRF2 to translocate into the nucleus and promote the transcription of target genes such as CD48, CD86, and CEACAM1, which are involved in immune response modulation (Li2024SAMSN1).

In the context of glioblastoma multiforme (GBM), SAMSN1 interacts with Sin3-associated polypeptide 30 (SAP30) and histone deacetylase 1 (HDAC1) in the nucleus, forming a stable complex that enhances HDAC1 activity. This interaction is significant as HDAC1 is associated with various cancers, including glioma (Yan2013SAMSN1).

SAMSN1 also binds to cortactin, a component of integrin signaling and cell migration, which is conserved in humans. This interaction suggests a role for SAMSN1 in cell migration and possibly in the progression of multiple myeloma (Amend2015Whole). These interactions highlight SAMSN1's involvement in both immune regulation and cancer pathogenesis.


## References


1. (Li2024SAMSN1) SAMSN1 causes sepsis immunosuppression by inducing macrophages to express coinhibitory molecules that causes T cell exhaustion via KEAP1-NRF2 signaling. This article has 0 citations.

[2. (Gitton2002A) Yorick Gitton, Nadia Dahmane, Sonya Baik, Ariel Ruiz i Altaba, Lorenz Neidhardt, Manuela Scholze, Bernhard G. Herrmann, Pascal Kahlem, Alia Benkahla, Sabine Schrinner, Reha Yildirimman, Ralf Herwig, Hans Lehrach, and Marie-Laure Yaspo. A gene expression map of human chromosome 21 orthologues in the mouse. Nature, 420(6915):586–590, December 2002. URL: http://dx.doi.org/10.1038/nature01270, doi:10.1038/nature01270. This article has 91 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature01270)

[3. (Yamada2008Detailed) Hideki Yamada, Kiyoshi Yanagisawa, Shogo Tokumaru, Ayumu Taguchi, Yuji Nimura, Hirotaka Osada, Masato Nagino, and Takashi Takahashi. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11‐21 in human lung cancer. Genes, Chromosomes and Cancer, 47(9):810–818, June 2008. URL: http://dx.doi.org/10.1002/gcc.20582, doi:10.1002/gcc.20582. This article has 74 citations.](https://doi.org/10.1002/gcc.20582)

[4. (Yan2013SAMSN1) Yong Yan, Lei Zhang, Tao Xu, Jinxu Zhou, Rong Qin, Chao Chen, Yongxiang Zou, Da Fu, Guohan Hu, Juxiang Chen, and Yicheng Lu. Samsn1 is highly expressed and associated with a poor survival in glioblastoma multiforme. PLoS ONE, 8(11):e81905, November 2013. URL: http://dx.doi.org/10.1371/journal.pone.0081905, doi:10.1371/journal.pone.0081905. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0081905)

5. (jiang2015contribution) The contribution of genetic variation to development of systemic lupus erythematosus. This article has 0 citations.

[6. (Amend2015Whole) Sarah R. Amend, William C. Wilson, Liang Chu, Lan Lu, Pengyuan Liu, Daniel Serie, Xinming Su, Yalin Xu, Dingyan Wang, Anthony Gramolini, Xiao-Yan Wen, Julie O’Neal, Michelle Hurchla, Celine M. Vachon, Graham Colditz, Ravi Vij, Katherine N. Weilbaecher, and Michael H. Tomasson. Whole genome sequence of multiple myeloma-prone c57bl/kalwrij mouse strain suggests the origin of disease involves multiple cell types. PLOS ONE, 10(5):e0127828, May 2015. URL: http://dx.doi.org/10.1371/journal.pone.0127828, doi:10.1371/journal.pone.0127828. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0127828)